MCO
78
3
ITW
64
2
AEP
56
-3
TXT
60
2
T
54
-6
PPG
66
2
VTR
47
-8
WMT
63
-3
CHD
48
-5
PYPL
47
2
MAR
53
3
MAT
54
3
CHK
35
8
SIG
60
2
EXPD
56
3
PEG
71
-3
BDX
46
2
A
46
3
FCX
58
5
PX
56
4
MCO
78
3
ITW
64
2
AEP
56
-3
TXT
60
2
T
54
-6
PPG
66
2
VTR
47
-8
WMT
63
-3
CHD
48
-5
PYPL
47
2
MAR
53
3
MAT
54
3
CHK
35
8
SIG
60
2
EXPD
56
3
PEG
71
-3
BDX
46
2
A
46
3
FCX
58
5
PX
56
4
Financhill
Back

OptimizeRx Vs. Amedisys Industry Stock Comparison

Sell
29

OPRX
OptimizeRx

Last Price:
7.86
Seasonality Move:
7.72%
Buy
55

AMED
Amedisys

Last Price:
97.19
Seasonality Move:
3.98%
Sell
29
OptimizeRx (OPRX) is a Sell

Is OptimizeRx a Buy, Sell or Hold?

  • The current OptimizeRx [OPRX] share price is $7.86. The Score for OPRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • OPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Amedisys (AMED) is a Buy

Is Amedisys a Buy, Sell or Hold?

  • The current Amedisys [AMED] share price is $97.18. The Score for AMED is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • AMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OPRX Stock Price Chart

What is OptimizeRx's stock price today?

  • The OptimizeRx share price today is $7.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing slight selling pressure.

AMED Stock Price Chart

What is Amedisys's stock price today?

  • The Amedisys share price today is $97.18
    The current trend is relatively stagnant and AMED is experiencing slight selling pressure.

OPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 45.32 Sell
Chaikin Money Flow: -3687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.56 - 8.4) Sell
Bollinger Bands (100): (8.46 - 11.56) Sell

AMED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 47.14 Sell
Chaikin Money Flow: -8431 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (97.06 - 97.98) Sell
Bollinger Bands (100): (93.25 - 98.27) Buy

OPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.63 Buy
20-day SMA: 7.86 Sell
50-day SMA: 8.9 Sell
200-day SMA: 11.58 Sell
8-day EMA: 7.72 Buy
20-day EMA: 7.92 Sell
50-day EMA: 8.71 Sell
200-day EMA: 10.76 Sell

AMED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.04 Buy
20-day SMA: 97.38 Sell
50-day SMA: 97.71 Sell
200-day SMA: 94.63 Buy
8-day EMA: 97.15 Buy
20-day EMA: 97.32 Sell
50-day EMA: 97.05 Buy
200-day EMA: 95.06 Buy

OptimizeRx Earnings Growth & OPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.

Amedisys Earnings Growth & AMED Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.13 per share, an increase this year of $0.30 per share, and an increase next year of $0.48 per share.

OptimizeRx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amedisys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):